1. Braun J, Landewé R, Hermann KG et al. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 2006; 54:1646–52.
2. Davis J, van der Heijde D, Braun J et al. Recombinant human tumor necrosis factor receptor (Etanercept) for treating ankylosing spondylitis A randomized, controlled trial. Arthritis Rheum 2003; 48:3230–6
3. van der Heijde D, Kivitz A, Schiff M et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006:54:2136–2.
4. Schett G, Landewé R, Desiree van der Heijde D. TNF blockers and structural remodeling in ankylosing spondylitis-what is reality and what is fiction? Ann Rheum Dis 2007; 66:709–11.
5. Schett G, Redlich K, Smolen JS. Inflammation-induced bone loss in the rheumatic diseases. In: Favus MJ, Ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th Edition. Washington D.C.: ASBMR, 2006; 6:310–313.